NO20082133L - Immunoglobulin-fusjonsproteinformuleringer - Google Patents

Immunoglobulin-fusjonsproteinformuleringer

Info

Publication number: NO20082133L
Authority: NO; Norway
Prior art keywords: fusion protein; compositions; immunoglobulin fusion; protein formulations; lyophilized
Prior art date: 2005-11-22

Application number

NO20082133A

Other languages

English (en)

Norwegian (no)

Inventor

Li Li

Nicholas W Warne

Anthony Barry

Thomas Crowley

Daniel Dixon

Jennifer Juneau

Ajaj Kumar

Nicholas Luksha

Michael Shamashkin

Erin Soley

Chandra A Webb

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-22

Filing date

2008-05-07

Publication date

2008-06-16

2008-05-07 Application filed by Wyeth Corp filed Critical Wyeth Corp

2008-06-16 Publication of NO20082133L publication Critical patent/NO20082133L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO20082133A 2005-11-22 2008-05-07 Immunoglobulin-fusjonsproteinformuleringer NO20082133L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US73927105P	2005-11-22	2005-11-22
PCT/US2006/045059 WO2007062040A1 (fr)	2005-11-22	2006-11-21	Preparations a base de proteines hybrides d'immunoglobuline

Publications (1)

Publication Number	Publication Date
NO20082133L true NO20082133L (no)	2008-06-16

Family

ID=37781927

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20082133A NO20082133L (no)	2005-11-22	2008-05-07	Immunoglobulin-fusjonsproteinformuleringer

Country Status (14)

Country	Link
US (2)	US20070237758A1 (fr)
EP (1)	EP1951305A1 (fr)
JP (1)	JP2009516692A (fr)
KR (1)	KR20080071192A (fr)
CN (1)	CN101312744A (fr)
AU (1)	AU2006318583A1 (fr)
BR (1)	BRPI0618893A2 (fr)
CA (1)	CA2630115A1 (fr)
CR (1)	CR10012A (fr)
EC (1)	ECSP088459A (fr)
NO (1)	NO20082133L (fr)
RU (1)	RU2008118166A (fr)
SV (1)	SV2009002911A (fr)
WO (1)	WO2007062040A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2390354T3 (es) *	2005-07-22	2012-11-12	Amgen, Inc	Liofilizados de proteínas concentrados, procedimientos y usos
BRPI0806313A2 (pt) *	2007-01-09	2011-09-06	Wyeth Corp	Formulação de anticorpo anti-il-13; formulação em aerossol de um anticorpo anti-il-13; formulaçãoliofilizada de um anticorpo anti-il-13; composição farmacêutica para o tratamento de um transtorno relacionado a il-13; fabricação de uma composição farmacêutica ; método de tratamento de um transtorno relacionado a il-13; seringa injetável; dispositivo para administração nasal; emplastro transdérmico; bolsa intravenosa; kit compreendendo pelo menos um recipiente; kit; e seringa injetável previamente enchida
CA2677937A1 (fr) *	2007-02-16	2008-08-21	Wyeth	Utilisation de saccharose pour supprimer une agregation de proteines provoquee par du mannitol
JP5469077B2 (ja) *	2007-11-12	2014-04-09	アレストレーディングソシエテアノニム	Ｔａｃｉ−免疫グロブリン融合タンパク質のための調製物
JO3672B1 (ar)	2008-12-15	2020-08-27	Regeneron Pharma	أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
AR076284A1 (es)	2009-04-29	2011-06-01	Bayer Schering Pharma Ag	Inmunoconjugados de antimesotelina y usos de los mismos
CN102695499A (zh) *	2009-06-18	2012-09-26	惠氏有限责任公司	小模块免疫药物的冻干制剂
CN101693016B (zh) *	2009-11-02	2012-07-25	北京美福源生物医药科技有限公司	通用的注射用重组人血清白蛋白融合蛋白制剂配方
AU2010315325B2 (en)	2009-11-03	2014-11-27	Grifols Therapeutics Inc.	Composition, method, and kit for alpha-1 proteinase inhibitor
AU2010324839B2 (en) *	2009-11-24	2015-02-19	Grifols Therapeutics Inc.	Lyophilization methods, compositions, and kits
JO3417B1 (ar)	2010-01-08	2019-10-20	Regeneron Pharma	الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
AU2012210481B2 (en)	2011-01-28	2017-05-18	Sanofi Biotechnology	Pharmaceutical compositions comprising human antibodies to PCSK9
AR087305A1 (es)	2011-07-28	2014-03-12	Regeneron Pharma	Formulaciones estabilizadas que contienen anticuerpos anti-pcsk9, metodo de preparacion y kit
TWI589299B (zh)	2011-10-11	2017-07-01	再生元醫藥公司	用於治療類風濕性關節炎之組成物及其使用方法
CN104940926B (zh)	2014-09-25	2017-09-22	信达生物制药(苏州)有限公司	重组融合蛋白制剂
CN105435222B (zh)	2014-09-25	2018-05-29	信达生物制药(苏州)有限公司	重组融合蛋白制剂
GB201513010D0 (en) *	2015-07-23	2015-09-09	Glaxosmithkline Biolog Sa	Novel formulation
JP2018523684A (ja)	2015-08-18	2018-08-23	リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎＰｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ．	リポタンパク質アフェレーシスを受けている高脂血症の患者を治療するための抗ｐｃｓｋ９阻害抗体
CA3099551C (fr)	2018-05-10	2025-08-19	Regeneron Pharma	Formulations contenant des proteines de fusion du recepteur vegf a haute concentration
WO2020021330A2 (fr) *	2018-07-12	2020-01-30	Endo Global Aesthetics Limited	Techniques d'injection pour le traitement de la cellulite
CN118267895A (zh) *	2018-10-30	2024-07-02	中国科学院化学研究所	一种制备药物或药物中间体无定型物的方法
CN111195349B (zh) *	2018-11-16	2023-02-24	鲁南制药集团股份有限公司	一种代谢调节融合蛋白的冻干粉制剂
WO2020142701A1 (fr) *	2019-01-06	2020-07-09	Endo Global Aesthetics Limited	Formulations de collagénase et leurs procédés de production
KR20210122810A (ko)	2019-01-31	2021-10-12	사노피 바이오테크놀로지	청소년 특발성 관절염을 치료하기 위한 항 il-6 수용체 항체
SG11202108627SA (en)	2019-02-18	2021-09-29	Lilly Co Eli	Therapeutic antibody formulation
CN114651010A (zh)	2019-04-24	2022-06-21	赛诺菲生物技术公司	类风湿性关节炎的诊断和治疗方法
EP3980459A1 (fr)	2019-06-04	2022-04-13	Sanofi Biotechnology	Compositions et procédés de traitement de la douleur chez des sujets atteints de polyarthrite rhumatoïde
CN113125489A (zh) *	2019-12-31	2021-07-16	上海药明生物技术有限公司	生物制剂配方优化和工艺优化的方法和系统

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4597966A (en) *	1985-01-09	1986-07-01	Ortho Diagnostic Systems, Inc.	Histidine stabilized immunoglobulin and method of preparation
US5843707A (en) *	1992-10-23	1998-12-01	Genetics Institute, Inc.	Nucleic acid encoding a novel P-selectin ligand protein
US6372716B1 (en) *	1994-04-26	2002-04-16	Genetics Institute, Inc.	Formulations for factor IX
US6685940B2 (en) *	1995-07-27	2004-02-03	Genentech, Inc.	Protein formulation
EP1516628B1 (fr) *	1995-07-27	2013-08-21	Genentech, Inc.	Formulation de protéine stabile, lyophilisée et isotonique
US5763401A (en) *	1996-07-12	1998-06-09	Bayer Corporation	Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
JP3900664B2 (ja) *	1997-09-26	2007-04-04	株式会社ニコン	顕微鏡
US7198789B2 (en) *	1998-03-17	2007-04-03	Genetics Institute, Llc	Methods and compositions for modulating interleukin-21 receptor activity
CZ300547B6 (cs) *	1999-02-22	2009-06-10	University Of Connecticut	Nové formulace faktoru VIII prosté albuminu
WO2000066160A1 (fr) *	1999-04-28	2000-11-09	Yamanouchi Pharmaceutical Co., Ltd.	Composition medicamenteuse parenterale a fragment d'anticorps monoclonal humanise et procede de stabilisation
ATE402716T1 (de) *	2002-02-27	2008-08-15	Immunex Corp	Stabilisierte tnfr-fc formulierung mit arginin
CA2554018A1 (fr) *	2004-03-04	2005-09-29	Wyeth	Procede de lyophilisation permettant d'ameliorer la cristallisation de l'excipient

2006
- 2006-11-21 KR KR1020087015109A patent/KR20080071192A/ko not_active Withdrawn
- 2006-11-21 US US11/562,299 patent/US20070237758A1/en not_active Abandoned
- 2006-11-21 AU AU2006318583A patent/AU2006318583A1/en not_active Abandoned
- 2006-11-21 RU RU2008118166/15A patent/RU2008118166A/ru not_active Application Discontinuation
- 2006-11-21 EP EP06838185A patent/EP1951305A1/fr not_active Withdrawn
- 2006-11-21 CA CA002630115A patent/CA2630115A1/fr not_active Abandoned
- 2006-11-21 JP JP2008541422A patent/JP2009516692A/ja not_active Withdrawn
- 2006-11-21 CN CNA2006800437873A patent/CN101312744A/zh active Pending
- 2006-11-21 WO PCT/US2006/045059 patent/WO2007062040A1/fr not_active Ceased
- 2006-11-21 BR BRPI0618893-1A patent/BRPI0618893A2/pt not_active IP Right Cessation
2008
- 2008-05-07 NO NO20082133A patent/NO20082133L/no not_active Application Discontinuation
- 2008-05-19 EC EC2008008459A patent/ECSP088459A/es unknown
- 2008-05-22 SV SV2008002911A patent/SV2009002911A/es unknown
- 2008-05-22 CR CR10012A patent/CR10012A/es not_active Application Discontinuation
2010
- 2010-10-22 US US12/910,146 patent/US20110033464A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR20080071192A (ko)	2008-08-01
EP1951305A1 (fr)	2008-08-06
RU2008118166A (ru)	2009-12-27
AU2006318583A1 (en)	2007-05-31
ECSP088459A (es)	2008-06-30
US20070237758A1 (en)	2007-10-11
SV2009002911A (es)	2009-03-04
US20110033464A1 (en)	2011-02-10
CN101312744A (zh)	2008-11-26
CA2630115A1 (fr)	2007-05-31
JP2009516692A (ja)	2009-04-23
BRPI0618893A2 (pt)	2011-09-13
CR10012A (es)	2008-07-29
WO2007062040A1 (fr)	2007-05-31

Publication	Publication Date	Title
NO20082133L (no)	2008-06-16	Immunoglobulin-fusjonsproteinformuleringer
NO20065084L (no)	2006-12-01	Interferon-alfa polypeptider og konjugater
CY1116285T1 (el)	2017-02-08	Ανασυνδυασμενες ν-γλυκοζυλιωμενες πρωτεϊνες απο προκαρυωτικα κυτταρα
NO20074278L (no)	2007-11-20	Tigecyklinblandinger og fremgangsmater for fremstilling
WO2004042017A3 (fr)	2004-07-15	Methodes et compositions pouvant augmenter la production d'anticorps
DK1422237T3 (da)	2007-06-11	Fremgangsmåder til rekombinant frembringelse af antifusogene peptider
RU2009149604A (ru)	2011-07-20	Способ предоставления устойчивого к температуре миорелаксанта на основе нейротоксичного компонента ботулинического токсина в твердой форме
BR112012013330A2 (pt)	2017-03-28	composições e métodos para aumentar meia vida do soro de proteínas de fusão fc
EA201100070A1 (ru)	2011-10-31	Туберкулезный белок rv2386c, композиции и их применения
AR054667A1 (es)	2007-07-11	Composicion hemostatica que comprende acido hialuronico
DK1513937T3 (da)	2011-05-16	Fremgangsmåde til den samtidige produktion af multiple proteiner; vektorer og celler til anvendelse derved
WO2012018639A3 (fr)	2012-07-05	Compositions de stabilisation d'adn, d'arn, de protéines salivaires et d'autres échantillons biologiques lors du transport et du stockage à températures ambiantes
ES2379283T3 (es)	2012-04-24	Proteínas de unión a albúmina sérica
NO20052363L (no)	2005-08-08	Interferon-alfa polypeptider og konjugater
WO2004099231A3 (fr)	2006-03-16	Methode de glycopegylation et proteines/peptides produits au moyen de ces methodes
WO2005047511A3 (fr)	2005-11-24	Expression bacterienne d'inhibiteurs de protease et variants de ceux-ci
WO2006094988A3 (fr)	2006-11-23	Melanges de polyphenylene-poly(aryl ether sulfone), articles et procede associes
WO2006020935A3 (fr)	2007-03-08	Preparations stabilisatrices
CY1110157T1 (el)	2015-01-14	Χιμαιρικα ανασυνδυασμενα αντιγονα του toxoplasma gondii
DK1379671T3 (da)	2009-06-29	Fremgangsmåder til dyrkning af circovirus
EA201100071A1 (ru)	2011-10-31	Новые композиции и способы
DK1610819T3 (da)	2013-09-02	Stabiliserende formulering til immunoglobulin-G-sammensætninger i flydende eller frysetørret form
WO2004024750A3 (fr)	2004-11-04	Ligands liant cd44
AR063899A1 (es)	2009-02-25	Materiales plasticos
DK1675956T3 (da)	2010-11-22	Minimal DNA-sekvens, der virksom som chromatinisolator, og dennes anvendelse til proteinekspression

Legal Events

Date	Code	Title	Description
2010-06-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application